On May 8, 2026 Prokarium reported that it will present at the American Urology Association (AUA) Annual Meeting.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr Michael Oefelein will be presenting on behalf of Prokarium at the American Urology Association (AUA) Annual Meeting, Washington, DC, 15-18th May 2026.

Presentation information:

Presentation Title: PD09-03: PARADIGM 1 – A multi-center Phase 1 study evaluating the safety and clinical effect of a novel microbial immunotherapeutic (ZH9) in patients with relapsed NMIBC – A first interim review
Session Title: PD09: Bladder Cancer: Non-invasive III
Session Date and Time: Saturday 16th May, 07:00 – 09:00

(Press release, Prokarium, MAY 8, 2026, View Source [SID1234665387])